# Combination Pain Therapy in HIV Neuropathy

> **NCT00863057** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 15 (actual)

## Conditions studied

- HIV Infections
- Peripheral Neuropathy

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Duloxetine placebo
- **DRUG:** Methadone
- **DRUG:** Methadone placebo

## Key facts

- **NCT ID:** NCT00863057
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Due to slow rate of enrollment, which compromised the ability to meet study objectives in a timely manner.
- **Last updated:** 2021-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00863057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00863057, "Combination Pain Therapy in HIV Neuropathy". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00863057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*